Mixlab Expands Midwest Operations with the Acquisition of The Pet Apothecary and SBH’s Veterinary Business
My Vet Candy My Vet Candy

Mixlab Expands Midwest Operations with the Acquisition of The Pet Apothecary and SBH’s Veterinary Business

Mixlab, the leading modern veterinary pharmacy, has acquired The Pet Apothecary, a Wisconsin-based local pet pharmacy, and the veterinary business of SBH Medical, an Ohio-based compounding pharmacy, with continued financial backing from Vanterra Ventures joined by PLUS Capital. These strategic acquisitions mark a significant expansion of Mixlab’s footprint in the Midwest, tripling its network of veterinary partners in the region. Mixlab will leverage its proprietary technology platform and streamlined processes to create a better pharmacy experience, and fuel continued growth.

Read More
Resilience in the Face of Fire: How California’s Wildfires Are Impacting Animals and the Heroes Helping Them
My Vet Candy My Vet Candy

Resilience in the Face of Fire: How California’s Wildfires Are Impacting Animals and the Heroes Helping Them

California wildfires have long been a source of devastation for both humans and animals, and this year’s fires have hit hard yet again. In the January 13, 2025, episode of Vet Candy, we focus on the toll these wildfires are taking on animals, how veterinarians are stepping up to help, and the ways the community is coming together to provide critical aid.

Read More
FDA Solicits Public Comments on Use of Cannabis-Derived Products in Veterinary Medicine
My Vet Candy My Vet Candy

FDA Solicits Public Comments on Use of Cannabis-Derived Products in Veterinary Medicine

The U.S. Food and Drug Administration’s Center for Veterinary Medicine has released a request for information (RFI) soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDP) in animals. The focus of this RFI is on cannabidiol (CBD) products and other products derived from hemp. The FDA is interested in general trends associated with these products, such as information about usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns.

Read More